🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Elizabeth Holmes sentenced to more than 11 years in prison for Theranos fraud

Published 11/18/2022, 06:09 AM
Updated 11/18/2022, 06:21 PM
© Reuters. FILE PHOTO: Theranos founder Elizabeth Holmes  and her family leave the federal courthouse after attending her fraud trial in San Jose, California, U.S. January 3, 2022.  REUTERS/Brittany Hosea-Small/File Photo

By Jody Godoy and Dan Levine

SAN JOSE, Calif. (Reuters) -A California judge sentenced Theranos founder Elizabeth Holmes to 11 years and three months in prison for defrauding investors in her now-defunct blood testing startup that was once valued at $9 billion.

U.S. District Judge Edward Davila in San Jose, Calif., sentenced Holmes on three counts of investor fraud and one count of conspiracy. A jury convicted Holmes, 38, in January following a trial that spanned three months.

Holmes, dressed in a dark blouse and black skirt, hugged her parents and her partner after the sentence was handed down.

During the hearing, Holmes cried as she said she was "devastated" by her failures and would have done many things differently if she had the chance.

"I have felt deep shame for what people went through because I failed them," she said.

Before handing down the sentence, Davila called the case "troubling on so many levels," questioning what motivated Holmes, a "brilliant" entrepreneur, to misrepresent her company to investors.

"This is a fraud case where an exciting venture went forward with great expectations only to be dashed by untruths, misrepresentations, plain hubris and lies," he said.

The judge set Holmes' surrender date for April. Her lawyers are expected to ask the judge to allow her to remain free on bail during her appeal.

Assistant U.S. Attorney Jeff Schenk told the judge before he handed down the sentence that a 15-year sentence would be "making a statement that the ends don't justify the means."

Holmes' attorney Kevin Downey sought home confinement for Holmes, saying leniency was justified because unlike someone who committed a "great crime" she was not motivated by greed.

The federal probation office had recommended a 9-year prison sentence, according to court papers.

Prosecutors and an attorney for Holmes declined to comment as they left court.

Prosecutors said at trial that Holmes misrepresented Theranos' technology and finances, including by claiming that its miniaturized blood testing machine was able to run an array of tests from a few drops of blood. The company secretly relied on conventional machines from other companies to run patients' tests, prosecutors said.

Holmes testified in her own defense, saying she believed her statements were accurate at the time.

Though she was convicted on four counts, Holmes was acquitted on four other counts alleging she defrauded patients who paid for Theranos tests.

Once valued at $9 billion, Theranos Inc promised to revolutionize how patients receive diagnoses by replacing traditional labs with small machines envisioned for use in homes, drugstores and even on the battlefield.

Forbes dubbed Holmes the world's youngest female self-made billionaire in 2014, when she was 30 and her stake in Theranos was worth $4.5 billion.

But the startup collapsed after a series of articles in the Wall Street Journal in 2015 questioned its technology.

Holmes is expected to challenge her sentence and Davila's rulings upholding her convictions at the 9th U.S. Circuit Court of Appeals.

Before handing down the sentence, Davila asked if any victims of Holmes' fraud were in court.

Alex Shultz, whose son Tyler Shultz worked at Theranos and whose father, former U.S. Secretary of State George Shultz, invested in the company, told the judge how a family member once heard Holmes describe her supposedly revolutionary technology.

"What's the hitch?'" the family member asked Holmes,

© Reuters. Theranos founder Elizabeth Holmes arrives with her family and partner Billy Evans to be sentenced on her convictions for defrauding investors in the blood testing startup at the federal courthouse in San Jose, California, U.S., November 18, 2022.  REUTERS/Brittany Hosea-Small

according to Shultz.

"There is no hitch," Holmes responded.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.